CEO Blog

How will we get America immunized? Here are a few hundred thousand suggestions

Operation Warp Speed leaders predicted that 20 million people, primarily frontline health care workers and residents of long-term care facilities, would receive the first dose of a COVID-19 vaccine in December. It’s now January, and media reports indicate that we’ve yet to break 5 million.

As with anything new, there will be bumps in the road as untested models are implemented. We are only in Phase 1a, and already we are seeing a need to refine the process. As more COVID-19 vaccines become available and more individuals become eligible to receive it, increased access points and optimal use of pharmacy teams will be critical to vaccinating more than 328 million Americans. We have got to kick this up a notch.

Words are inadequate

2020 was a year many of us would like to forget, but that’s impossible; its changes are irrevocable. APhA has a proud history of supporting pharmacists and advancing pharmacy practice. In 2020, we sped forward as the world caught fire, and the paths we once tread are shrinking in our rearview mirror. This was the first year of a new era for pharmacy.

You’ve heard me describe the profession’s 2020 progress before—the new practice authorities, the movement toward payment reform, the attention to workplace conditions.

My statement on the presidential election

I want to share with you my statement on the presidential election. APhA will continue to inform you on our advocacy work before and after the inauguration.

The statement:

“The American Pharmacists Association welcomes the opportunity to work with the new administration and the 117th Congress to continue recognizing pharmacists as medical experts providing patient care. Chief among these are efforts to secure pharmacist provider status for Medicare coverage, and advocating for fundamental payment reform for pharmacists’ services.

Rutledge v PCMA arguments: Thumbs up or thumbs down?

For today’s blog, I invited Ilisa Bernstein, APhA’s senior vice president for pharmacy practice and government affairs, to share her thoughts on this week’s big Supreme Court case from her perspective as both a pharmacist and a lawyer. 

By Ilisa Bernstein

Finally, oral arguments in Rutledge v PCMA were heard this week. The pharmacy community has been eagerly awaiting the showdown at the U.S. Supreme Court on this case involving the state of Arkansas against the Pharmaceutical Care Management Association, the association representing pharmacy benefit managers (PBMs). 

Today was a historic day for pharmacists and their patients

Today, after decades of pharmacy advocates fighting at the federal and state levels to gain better control of drug pricing and protect the viability of community pharmacies, the Justices of the Supreme Court of the United States heard oral arguments in Rutledge v Pharmaceutical Care Management Association (PCMA), which may finally determine whether states can control the terrible business practices of PBMs. Finally, the most critical grievances of our profession have been heard in the highest court of the land. Learn more about the case. Missed it? Don’t worry. A recording of the session can be heard here.